Recent Articles
Crispr Stock Is Volatile, but Worth the Wait as a Buy-and-Hold Biotech Play
This Swiss biotechnology company works on the cutting edge of gene editing and Crispr stock is a play on future treatments.
You Really Need to Have Cloudfare Stock on Your Watchlist
More demand for the company’s behind-the-scenes internet services make NET stock attractive for long-term investors.
Weakened Beyond Meat Stock Faces Stiff Challenges Even Without Covid
The recent drop in BYND stock reminds Beyond Meat investors that they can’t assume rapid growth will survive the pandemic and competition.
Pass on Hyliion Holding Corp.’s Shares for Now
Investors have better choices than Hyliion Stock to play the EV trucking segment in the wake of criticism and a massive drop in share prices.
Steer Clear of Kaixin Auto Stock as Turmoil Continues to Swirl
Investors should avoid KXIN stock as corporate instability dominates this Chinese auto dealer and volatility surrounds its shares.
Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.
